China National Accord Medicines Corporation Ltd. (SHE:000028)
24.80
+0.11 (0.45%)
Apr 29, 2026, 3:04 PM CST
SHE:000028 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | - | 7,802 | 7,409 | 6,502 | 6,016 | 5,126 | Upgrade
|
| Cash & Short-Term Investments | 7,802 | 7,802 | 7,409 | 6,502 | 6,016 | 5,126 | Upgrade
|
| Cash Growth | 40.79% | 5.32% | 13.94% | 8.08% | 17.37% | -18.44% | Upgrade
|
| Accounts Receivable | - | 22,939 | 21,118 | 20,235 | 16,202 | 17,701 | Upgrade
|
| Other Receivables | - | 132.22 | 146.41 | 265.56 | 66.85 | 87.26 | Upgrade
|
| Receivables | - | 23,071 | 21,294 | 20,539 | 16,306 | 17,855 | Upgrade
|
| Inventory | - | 8,122 | 7,406 | 7,989 | 7,836 | 7,622 | Upgrade
|
| Other Current Assets | - | 1,200 | 1,467 | 1,340 | 1,550 | 1,246 | Upgrade
|
| Total Current Assets | - | 40,196 | 37,576 | 36,370 | 31,708 | 31,848 | Upgrade
|
| Property, Plant & Equipment | - | 2,692 | 3,479 | 3,724 | 3,407 | 3,494 | Upgrade
|
| Long-Term Investments | - | 3,278 | 3,080 | 2,947 | 2,799 | 2,658 | Upgrade
|
| Goodwill | - | 1,605 | 1,859 | 2,747 | 2,750 | 2,776 | Upgrade
|
| Other Intangible Assets | - | 406.69 | 479.54 | 615.59 | 647.52 | 669.93 | Upgrade
|
| Long-Term Accounts Receivable | - | 1.72 | 12.93 | 15.91 | 13.68 | 16.59 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 308.72 | 249.41 | 220.48 | 185.25 | 129.74 | Upgrade
|
| Long-Term Deferred Charges | - | 335.23 | 467.67 | 526.58 | 572.55 | 633.98 | Upgrade
|
| Other Long-Term Assets | - | 273.09 | 352.1 | 404.42 | 532.4 | 557.38 | Upgrade
|
| Total Assets | - | 49,096 | 47,556 | 47,571 | 42,616 | 42,784 | Upgrade
|
| Accounts Payable | - | 20,516 | 18,100 | 17,952 | 15,233 | 16,718 | Upgrade
|
| Accrued Expenses | - | 666.7 | 779.14 | 760.58 | 998.17 | 753.2 | Upgrade
|
| Short-Term Debt | - | 2,855 | 3,422 | 2,903 | 2,133 | 2,490 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 17 | 45.14 | - | Upgrade
|
| Current Portion of Leases | - | 740.45 | 944.37 | 1,002 | 867.85 | 848.33 | Upgrade
|
| Current Income Taxes Payable | - | 171.63 | 128.03 | 205.9 | 237.8 | 178.87 | Upgrade
|
| Current Unearned Revenue | - | 387.21 | 349.74 | 456.3 | 586.96 | 450.59 | Upgrade
|
| Other Current Liabilities | - | 768.63 | 1,079 | 1,041 | 926.05 | 939.8 | Upgrade
|
| Total Current Liabilities | - | 26,105 | 24,802 | 24,338 | 21,028 | 22,379 | Upgrade
|
| Long-Term Debt | - | - | - | - | 17.5 | 71.64 | Upgrade
|
| Long-Term Leases | - | 912.18 | 1,371 | 1,452 | 1,327 | 1,375 | Upgrade
|
| Long-Term Unearned Revenue | - | 69.28 | 69.48 | 74.97 | 80.91 | 87.72 | Upgrade
|
| Pension & Post-Retirement Benefits | - | 0.61 | 0.71 | 0.77 | 0.86 | 1.2 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 93.87 | 114.5 | 146.05 | 156.48 | 175.95 | Upgrade
|
| Other Long-Term Liabilities | - | 290.7 | 441.99 | 581.45 | 560.3 | 670.52 | Upgrade
|
| Total Liabilities | - | 27,472 | 26,800 | 26,593 | 23,171 | 24,761 | Upgrade
|
| Common Stock | - | 556.57 | 556.57 | 556.57 | 428.13 | 428.13 | Upgrade
|
| Additional Paid-In Capital | - | 4,268 | 4,261 | 4,261 | 4,357 | 4,372 | Upgrade
|
| Retained Earnings | - | 13,786 | 12,854 | 12,590 | 11,333 | 10,103 | Upgrade
|
| Comprehensive Income & Other | - | -0.28 | -1.45 | 7.87 | 7.91 | 21.87 | Upgrade
|
| Total Common Equity | 18,610 | 18,610 | 17,670 | 17,415 | 16,126 | 14,925 | Upgrade
|
| Minority Interest | - | 3,015 | 3,086 | 3,563 | 3,319 | 3,097 | Upgrade
|
| Shareholders' Equity | 21,624 | 21,624 | 20,755 | 20,978 | 19,445 | 18,022 | Upgrade
|
| Total Liabilities & Equity | - | 49,096 | 47,556 | 47,571 | 42,616 | 42,784 | Upgrade
|
| Total Debt | 4,507 | 4,507 | 5,737 | 5,374 | 4,391 | 4,786 | Upgrade
|
| Net Cash (Debt) | 3,295 | 3,295 | 1,671 | 1,129 | 1,626 | 340.48 | Upgrade
|
| Net Cash Growth | - | 97.18% | 48.07% | -30.58% | 377.51% | -82.99% | Upgrade
|
| Net Cash Per Share | 5.93 | 5.92 | 2.99 | 2.03 | 2.92 | 0.61 | Upgrade
|
| Filing Date Shares Outstanding | 552.81 | 556.57 | 556.57 | 556.57 | 556.57 | 556.57 | Upgrade
|
| Total Common Shares Outstanding | 552.81 | 556.57 | 556.57 | 556.57 | 556.57 | 556.57 | Upgrade
|
| Working Capital | - | 14,091 | 12,774 | 12,032 | 10,681 | 9,469 | Upgrade
|
| Book Value Per Share | 33.44 | 33.44 | 31.75 | 31.29 | 28.97 | 26.82 | Upgrade
|
| Tangible Book Value | 16,598 | 16,598 | 15,331 | 14,053 | 12,728 | 11,479 | Upgrade
|
| Tangible Book Value Per Share | 29.82 | 29.82 | 27.55 | 25.25 | 22.87 | 20.63 | Upgrade
|
| Buildings | - | 806.56 | 807.91 | 741.11 | 738.01 | 725.86 | Upgrade
|
| Machinery | - | 1,414 | 1,396 | 1,294 | 1,132 | 1,027 | Upgrade
|
| Construction In Progress | - | 21.66 | 12.6 | 35.44 | 35.17 | 49.85 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.